Abstract:<p>Antibody disulfide bond reduction has been a challenging issue in monoclonal antibody manufacturing. It could lead to decrease of product purity and failure to meet targeted product profile and/or specifications. More importantly, disulfide bond reduction could also impact drug safety and efficacy. Scientists across industry have been examining the root causes and developing mitigation strategies to address the challenge. In recent years, with the development of high titer mammalian cell culture processes to meet the rapidly growing demand for antibody biopharmaceuticals, disulfide bond reduction has been observed more frequently. Thus, it is necessary to continue evolving the disulfide reduction mitigation strategies and developing novel approaches to maintain high product quality. Additionally, in recent years as more complex molecules (such as bispecific and trispecific antibodies) emerge, the molecular heterogeneity due to incomplete formation of the interchain disulfide bonds becomes a more imperative challenging issue. Given the disulfide reduction challenges that biotech industry is facing, in this review, we provide a comprehensive scientific summary of the root cause analysis of disulfide reduction during process development of antibody therapeutics, mitigation strategies and its potential remediated recovery based on published papers. First, this paper intends to highlight different aspects of the root cause for disulfide reduction. Secondly, to provide a broader understanding of the disulfide bond reduction in downstream process, this paper discusses disulfide bond reduction impact on product stability, associated analytical methods for disulfide bond reduction detection and characterization, process control strategies as well as their manufacturing implementation. In addition, brief perspectives on the development of future mitigation strategies are also reviewed, including platform alignment, mitigation strategy application for the emerging new modalities such as bispecific and trispecific antibodies as well as using machine learning to identify molecule susceptibility of disulfide bond reduction. The data in this review are originated from the published papers.</p><p>This article is protected by copyright. All rights reserved.</p>

Fast and accurate disulfide bridge detection

Rapid Identification of Disulfide Bonds and Cysteine-Related Variants in an IgG1 Knob-into-Hole Bispecific Antibody Enhanced by Machine Learning

Automated high-throughput purification of antibody fragments to facilitate evaluation in functional and kinetic based assays.

Recent mass spectrometry-based techniques and considerations for disulfide bond characterization in proteins

Detecting Native Folds in Mixtures of Proteins That Contain Disulfide Bonds

Recent advancements in disulfide bridge characterization: Insights from mass spectrometry

High-Coverage Disulfide Mapping Enabled by Programmable Disulfide-Ene Reaction Integrated onto a Bottom-Up Protein Analysis Workflow

Detecting features of antibody structure through their mediator-accessible redox activities

Edman Degradation Reveals Unequivocal Analysis of the Disulfide Connectivity in Peptides and Proteins

Practical solutions for overcoming artificial disulfide scrambling in the non-reduced peptide mapping characterization of monoclonal antibodies

Systematic screening of soluble expression of antibody fragments in the cytoplasm of E. coli

Dynamics of Thiol/Disulfide Exchange Within a Single Protein

A simplified non-reduced peptide mapping method with faster and efficient enzymatic digestion for characterization of native disulfide bonds in monoclonal and bispecific antibodies

Antibody disulfide bond reduction and recovery during biopharmaceutical process development—A review

Unraveling disulfide-bond distribution of recombinant peptide by orthogonal protease digestion and MALDI-TOF/MS

Structure-function relationship study for sulfated protein therapeutics using hydrophobic interaction chromatography and mass spectrometry

Optimization and kinetic modeling of interchain disulfide bond reoxidation of monoclonal antibodies in bioprocesses

Streamlining the Characterization of Disulfide Bond Shuffling and Protein Degradation in IgG1 Biopharmaceuticals Under Native and Stressed Conditions

Mass spectrometry-based strategies for protein disulfide bond identification

An Integrated Strategy to Identify Tyrosine Sulfation from the Therapeutic Proteins

Diaminodiacid Bridges to Improve Folding and Tune the Bioactivity of Disulfide-Rich Peptides